Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Oral administration of bovine milk-derived extracellular vesicles induces senescence in the primary tumor but accelerates cancer metastasis
Wegovy pens allow 28 days at room temperature
Documentation and Prescription Requirements Carry your original prescription label on the semaglutide pen or vial, along with a letter from your healthcare provider confirming the medication is medically necessary for your weight management treatment
GLP-1 only treatments and oral options still deliver strong results but typically show slightly lower average weight loss because they target a single receptor pathway
Key points: In the only head-to-head trial, Wegovy produced 15.8% weight loss compared with 6.4% for Saxenda over the same 68-week period Wegovy 7.2 mg (approved January 2026) produces even greater results at 20.7% average weight loss Real-world data from Second Nature shows 19.1% weight loss with semaglutide when combined with behavioural support Semaglutide participants were nearly three times more likely to achieve at least 10% weight loss than liraglutide participants Side effects and tolerability Both medications share a similar side-effect profile, predominantly affecting the gastrointestinal tract
Aetna will not cover Ozempic, Wegovy, or any branded semaglutide for prediabetes
